ATA817077A - Verfahren zur herstellung neuer piperidin- derivate und ihrer salze - Google Patents

Verfahren zur herstellung neuer piperidin- derivate und ihrer salze

Info

Publication number
ATA817077A
ATA817077A AT817077A AT817077A ATA817077A AT A817077 A ATA817077 A AT A817077A AT 817077 A AT817077 A AT 817077A AT 817077 A AT817077 A AT 817077A AT A817077 A ATA817077 A AT A817077A
Authority
AT
Austria
Prior art keywords
salts
piperidine derivatives
producing new
new piperidine
producing
Prior art date
Application number
AT817077A
Other languages
English (en)
Other versions
AT360013B (de
Inventor
Armando Vega Dr Noverola
Jose Boix Dr Iglesias
Jose Prieto Dr Soto
Jacinto Morgues Dr Mauri
Robert Geoffrey Willi Spickett
Original Assignee
Anphar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anphar Sa filed Critical Anphar Sa
Publication of ATA817077A publication Critical patent/ATA817077A/de
Application granted granted Critical
Publication of AT360013B publication Critical patent/AT360013B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT817077A 1976-11-16 1977-11-15 Verfahren zur herstellung neuer piperidin- derivate und ihrer salze AT360013B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47739/76A GB1574418A (en) 1976-11-16 1976-11-16 Piperidine derivatives

Publications (2)

Publication Number Publication Date
ATA817077A true ATA817077A (de) 1980-05-15
AT360013B AT360013B (de) 1980-12-10

Family

ID=10446086

Family Applications (2)

Application Number Title Priority Date Filing Date
AT817077A AT360013B (de) 1976-11-16 1977-11-15 Verfahren zur herstellung neuer piperidin- derivate und ihrer salze
AT817177A AT360014B (de) 1976-11-16 1977-11-15 Verfahren zur herstellung neuer piperidin- derivate und ihrer salze

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT817177A AT360014B (de) 1976-11-16 1977-11-15 Verfahren zur herstellung neuer piperidin- derivate und ihrer salze

Country Status (13)

Country Link
US (1) US5026858A (de)
JP (2) JPS5390267A (de)
AT (2) AT360013B (de)
AU (2) AU517004B2 (de)
BE (2) BE860736A (de)
CA (2) CA1094072A (de)
DE (2) DE2751139A1 (de)
ES (4) ES464147A1 (de)
FR (2) FR2370732A1 (de)
GB (1) GB1574418A (de)
IE (2) IE45989B1 (de)
NL (2) NL7712559A (de)
ZA (2) ZA776587B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
FR2546169B1 (fr) * 1983-05-20 1986-03-21 Delalande Sa N-oxydes de derives aminocycliques, leur procede de preparation et leur application en therapeutique
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
AU4224993A (en) * 1992-08-19 1994-03-15 Pfizer Inc. Substituted benzylamino nitrogen containing non-aromatic heterocycles
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5885983A (en) * 1996-05-10 1999-03-23 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
KR20010081034A (ko) * 1998-11-20 2001-08-25 프리돌린 클라우스너, 롤란드 비. 보레르 피페리딘 씨씨알-3 수용체 길항제
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
WO2005053663A2 (en) * 2003-11-24 2005-06-16 Eli Lilly And Company Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
RU2403250C2 (ru) * 2005-06-02 2010-11-10 Ф.Хоффманн-Ля Рош Аг Производные пиперидин-4-иламида и их применение в качестве антагонистов рецептора sst подтипа 5
JP2009264436A (ja) 2008-04-23 2009-11-12 Funai Electric Co Ltd トルクリミッタ装置、トルクリミッタ装置を備えた表示画面旋回装置およびトルクリミッタ装置を含むテレビジョン装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1019781A (de) * 1963-03-05
FR1407055A (fr) * 1963-03-05 1965-07-30 Ile De France Nouveau procédé de préparation de benzamides substitués
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (de) * 1966-01-21 1968-05-06
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
GB1345872A (en) * 1970-09-03 1974-02-06 Wyeth John & Brother Ltd Amino-and acylamino-pyridine and hydropyridine derivatives
US3963745A (en) * 1972-04-03 1976-06-15 A. H. Robins Company, Incorporated Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides
DE2513136C3 (de) * 1974-03-21 1981-04-30 Anphar S.A., Madrid N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
US4163789A (en) * 1976-02-17 1979-08-07 Anphar, S.A. Anti-psychotic (cycloalkenylalkylpiperidino) benzamides
GB1513631A (en) * 1976-02-17 1978-06-07 Gallardo Antonio Sa Piperidine derivatives
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives

Also Published As

Publication number Publication date
FR2370733B1 (de) 1980-07-04
AT360013B (de) 1980-12-10
IE46090L (en) 1978-05-16
IE45989L (en) 1978-05-16
FR2370733A1 (fr) 1978-06-09
BE860737A (fr) 1978-03-01
AU3067377A (en) 1979-05-24
AU517830B2 (en) 1981-08-27
FR2370732B1 (de) 1980-07-04
DE2751139A1 (de) 1978-05-24
JPS5387365A (en) 1978-08-01
JPS6127388B2 (de) 1986-06-25
JPS6126782B2 (de) 1986-06-21
ES464144A1 (es) 1978-09-01
ES464145A1 (es) 1978-09-01
CA1094072A (en) 1981-01-20
ES464147A1 (es) 1978-09-01
ATA817177A (de) 1980-05-15
AT360014B (de) 1980-12-10
GB1574418A (en) 1980-09-03
NL7712570A (nl) 1978-05-18
IE45989B1 (en) 1983-01-26
US5026858A (en) 1991-06-25
BE860736A (fr) 1978-03-01
AU517004B2 (en) 1981-07-02
ZA776588B (en) 1978-08-30
DE2751138A1 (de) 1978-05-24
IE46090B1 (en) 1983-02-23
ES464146A1 (es) 1978-09-01
JPS5390267A (en) 1978-08-08
CA1095046A (en) 1981-02-03
FR2370732A1 (fr) 1978-06-09
ZA776587B (en) 1978-09-27
AU3067277A (en) 1979-05-24
NL7712559A (nl) 1978-05-18

Similar Documents

Publication Publication Date Title
AT352736B (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT367418B (de) Verfahren zur herstellung neuer tetrahydropyridinylindolderivate und ihrer salze
AT365181B (de) Verfahren zur herstellung neuer thiazolidinderivate und ihrer salze
AT360013B (de) Verfahren zur herstellung neuer piperidin- derivate und ihrer salze
AT350570B (de) Verfahren zur herstellung neuer thienopyridin- derivate und ihrer salze
AT371458B (de) Verfahren zur herstellung neuer benzopyranderivate und ihrer salze
AT355565B (de) Verfahren zur herstellung neuer thiazolin- derivate und ihrer salze
AT360513B (de) Verfahren zur herstellung neuer dimerer indol- -dihydroindol-carboxamide und ihrer salze
AT362350B (de) Verfahren zur herstellung neuer in 4-stellung substituierter 3-sulfamoylbenzoesaeuren und ihrer salze
ATA622077A (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
AT355014B (de) Verfahren zur herstellung neuer 2-benzopyranon- derivate und ihrer salze
ATA688677A (de) Verfahren zur herstellung neuer aminoimidazoiso- chinolinderivate und ihrer salze
ATA407977A (de) Verfahren zur herstellung neuer hydrazinopyridazinderivate und deren salzen
AT364830B (de) Verfahren zur herstellung neuer benzimidazol-2-derivate und ihrer salze
ATA338079A (de) Verfahren zur herstellung neuer 1-amino-2- -hydroxy-3-heterocyclyloxy-progane und ihrer salze
ATA165580A (de) Verfahren zur herstellung neuer benz-acylbenzimidazol-2-derivate und ihrer salze
ATA165680A (de) Verfahren zur herstellung neuer benz-acylbenzimidazol-2-derivate und ihrer salze
AT355582B (de) Verfahren zur herstellung neuer pyridobenzo- diazepinone und ihrer salze
ATA8479A (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
ATA429979A (de) Verfahren zur herstellung neuer 2,3-dihydro- -2-oxothiophenderivate und ihrer salze
ATA42580A (de) Verfahren zur herstellung neuer chinazolonderivateund ihrer salze
ATA777479A (de) Verfahren zur herstellung neuer in 4-stellung substituierter 3-sulfamoyl-5-pyrrolyl- bzw. -5-pyrrolylalkyl-benzoesaeuren und ihrer salze
AT362348B (de) Verfahren zur herstellung neuer naphthylamin- derivate und ihrer saeureadditionssalze
ATA554181A (de) Verfahren zur herstellung neuer ergolinderivate und ihrer salze
ATA554281A (de) Verfahren zur herstellung neuer ergolinderivate und ihrer salze

Legal Events

Date Code Title Description
EFA Change in the company name
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee